|
|
Medtronic Plc (NYSE: MDT) |
|
|
|
| |
Medtronic Plc's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 2.51% in the third quarter 2025, year on year to cumulative value of $33,199 million, Medtronic Plc's revenue per employee grew on a trailing twelve months basis to $ 331,990. The productivity of Medtronic Plc's employees was 0.0%, above the company average. Within the Healthcare sector Employees of 123 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1182, from total ranking in previous quarter at 1730. Medtronic Plc has 100,000 employees.
What is Sales per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| MDT Revenue per Employee |
(Jan 24 2025)
III. Quarter |
(Oct 25 2024)
II. Quarter |
(Jul 26 2024)
I. Quarter |
(Apr 26 2024)
IV. Quarter |
(Jan 26 2024)
III. Quarter |
| Y / Y Revenue Change |
2.51 % |
5.25 % |
2.77 % |
0.53 % |
4.68 % |
| Sales per Employee (TTM) $ |
331,990 |
329,960 |
325,770 |
323,640 |
323,190 |
| MDT's Total
Ranking |
# 1182 |
# 1730 |
# 1551 |
# 1524 |
# 972 |
| Seq. Revenue Change |
-1.32 % |
6.17 % |
-7.85 % |
6.18 % |
1.32 % |
| Revenue per Employee Statistics |
| High |
Average |
Low |
| $ 436,930 |
$ 237,042 |
$ 115,093 |
| (Jan 27 2017) |
|
(July 26. 2006) |
Date modified: 2025-02-26T13:29:17+00:00
| Companies with similar Revenue per Employee for 12 months ending Jan 24 2025, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Jan 24 2025 | Number of Employees Jan 24 2025 | | Ensysce Biosciences Inc | 578,892.33 | $ 5.210 Million | 9 | | Bicycle Therapeutics Plc | 578,278.69 | $ 35.275 Million | 61 | | Moderna Inc | 577,857.14 | $ 3,236.000 Million | 5,600 | | Sol gel Technologies Ltd | 576,900.00 | $ 11.538 Million | 20 | | Fortress Biotech Inc | 571,039.60 | $ 57.675 Million | 101 | | Phibro Animal Health Corporation | 569,646.91 | $ 1,105.115 Million | 1,940 | | Ginkgo Bioworks Holdings Inc | 567,607.50 | $ 227.043 Million | 400 | | Monte Rosa Therapeutics Inc | 564,343.28 | $ 75.622 Million | 134 | | Pacira Biosciences inc | 563,930.81 | $ 700.966 Million | 1,243 | | Vaxart Inc | 562,745.10 | $ 28.700 Million | 51 | | Organogenesis Holdings Inc | 559,214.62 | $ 482.043 Million | 862 | | Nature s Sunshine Products inc | 553,953.60 | $ 453.688 Million | 819 | | Neogen Corporation | 550,770.61 | $ 921.990 Million | 1,674 | | Schrodinger Inc | 549,044.97 | $ 207.539 Million | 378 | | Zynex inc | 542,068.57 | $ 189.724 Million | 350 | | Tango Therapeutics Inc | 539,346.15 | $ 42.069 Million | 78 | | Flora Growth Corp | 537,815.79 | $ 40.874 Million | 76 | | Edap Tms Sa | 535,878.21 | $ 71.808 Million | 134 | | Immucell Corp | 529,863.38 | $ 26.493 Million | 50 | | Harrow Inc | 521,908.38 | $ 199.369 Million | 382 | | Caredx Inc | 519,105.75 | $ 333.785 Million | 643 | | Natera Inc | 515,308.53 | $ 1,696.911 Million | 3,293 | | Tela Bio Inc | 514,947.37 | $ 68.488 Million | 133 | | Prophase Labs Inc | 510,750.00 | $ 12.258 Million | 24 | | Enanta Pharmaceuticals Inc | 508,328.24 | $ 66.591 Million | 131 | | Veracyte Inc | 505,699.39 | $ 412.145 Million | 815 | | Xtant Medical Holdings Inc | 505,241.38 | $ 117.216 Million | 232 | | Globus Medical Inc | 503,871.00 | $ 2,519.355 Million | 5,000 | | Avantor Inc | 502,488.89 | $ 6,783.600 Million | 13,500 | | Puma Biotechnology Inc | 501,017.39 | $ 230.468 Million | 460 |
|
